Procurement And Tender News

Tendersinfo keep you informed about the latest events in the national and international Procurement Industry. Procurement News provides in-depth coverage of the procurement industry, including contract awards, contract additions, new contract wins, mergers and acquisitions. Tendersinfo through its tender news section provides an update on all domestic and global tendering opportunities, invitation to bid & trade leads.

Australia : GP Co-payment and Medical Research Future Fund Essential Budget Reforms

Publish Date : 26-Aug-2014

Our proposal for a $7 co-payment to help cover the cost of accessing a medical service is an essential structural reform, which will help make public funding for our world class health care system sustainable for the long term. The key public policy challenge we face in health care financing is how best to ensure that all Australians can have timely and affordable access to high quality health care in a way that is also affordable for taxpayers over the medium to long term.

How do we ensure that the necessarily limited resources of taxpayers are deployed to maximum effect, to service all the genuine health care needs of a growing number of patients in the context of an ageing population over the next few decades and beyond. An appropriate price signal is a proven way to improve the efficiency of allocating limited resources to a growing demand for services.

It will help ensure that everyone in need of timely and affordable access to high quality health care can have that access in a way that is also affordable and sustainable for taxpayers. To completely exclude one of the largest and most rapidly growing user groups of medical services from such a price signal, as has been suggested by some, defeats its purpose. Under our proposed reform there are appropriate safeguards however, to ensure that no pensioner or other concession card holder would have to pay more than $70 a year for access to an unlimited supply of medical services.

The same applies to children under the age of 16. Labor asserts that a $70 a year co-payment for unlimited access to medical services for pensioners is unfair. Yet they support the $360 a year co-payment for pensioners to have access to pharmaceutical products.
Indeed, successive Labor governments since 1983 have supported co-payment arrangements for access to pharmaceuticals, including for pensioners and concession card holders, and the Hawke government sensibly sought to introduce a co-payment for access to medical services to put their public funding on a sustainable footing.

That was good public policy then and it is good public policy now. The only reason it did ultimately not happen then is because of internal Labor Party politics and division in government, not because the reforming Hawke government got the policy wrong. Now, Labor is making the entirely irrational argument that a $360 price signal a year for pensioners accessing pharmaceutical products is good, but a $70 a year price signal for unlimited access to medical services is bad. The reality is that the co-payment for access to medical services is unfinished business from the health care financing reform agenda initiated by the Hawke government in 1991. There is another Labor attack on our proposal which is wrong.

Go to previous page

Request for CallBack